PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10803320-0 2000 Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers. Paclitaxel 50-55 succinate dehydrogenase complex subunit D Homo sapiens 17-22 10803320-1 2000 CBT-1, a natural product, was studied as an MDR modulator with Taxol (135 mg/m2) in an escalating dose Phase I clinical trial. Paclitaxel 63-68 succinate dehydrogenase complex subunit D Homo sapiens 0-5